A second prescription can mark a point where a short course of pain treatment becomes a longer conversation. A University of Arkansas analysis published in MMWR on March 17, 2017 associated longer initial opioid episodes with greater estimated continuation. Its selected United States adult cohort was opioid-naive and cancer-free; the findings did not establish that patients seeking another prescription were misusing medication. [mm6610a1]

The study drew on insurance records from 2006–2015. An initial episode could include multiple prescriptions and gaps of up to 30 days. Pain severity and duration were unavailable, and the analysis did not consider the cause of pain. Those omissions matter at a refill handoff: a record of dispensing does not supply the clinical explanation for why someone still needed care. [mm6610a1]

CDC's 2016 guideline offered a different kind of information. It described voluntary recommendations, with decisions grounded in the patient's circumstances. Its principal scope was adult outpatient primary-care chronic pain, outside active cancer treatment, palliative care and end-of-life care. Its acute-pain discussion excluded postoperative treatment. That document supplies historical care context, not an automatic rule for every person in the later study. [rr6501e1]

Our public-interest reading is that scrutiny of repeat dispensing should include the opportunity to discuss ongoing pain, rather than count prescriptions alone. The researchers called for early conversations; the earlier guideline emphasized clinician-patient judgment. Neither measured whether easier follow-up access improved outcomes. This historical account therefore identifies a continuity-of-care question without prescribing treatment, equating continuation with addiction or advising anyone to change medication today. [mm6610a1][rr6501e1]

Source documents

  1. Characteristics of Initial Prescription Episodes and Likelihood of Long-Term Opioid Use — United States, 2006–2015https://www.cdc.gov/mmwr/volumes/66/wr/mm6610a1.htm
  2. CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016https://www.cdc.gov/mmwr/volumes/65/rr/rr6501e1.htm